Technical Problem
Current medical procedures for prostate biopsy and therapy face challenges with inaccurate needle placement due to dynamic tissue deformation and limited access within closed MRI scanners, where traditional robots and mechanical linkages are not compatible and suffer from low signal-to-noise ratio and invasive methods.
How it works
· Leveraging at least three degrees of freedom, has precise needle insertion and guidance within a closed MRI scanner
· Uses real-time imaging and passive or active tracking methods to minimize tissue deformation and ensure accurate targeting
· Compatible with high-field MRI scanners without artifacts, and capable of transrectal access
Value proposition
· See-and-treat in one step: Co-localized contrast and therapy let clinicians visualize, biopsy, and treat with a single platform
· Pinpoint delivery, less systemic exposure, and therapy concentrated at the tumor to help reduce off‑target effects
· Multi‑modality visibility: Designed for use with CT, MRI, X‑ray, and ultrasound to fit existing workflows.
· Flexible payloads and formulations: Supports therapeutic agents and nucleic acid vectors with carriers such as buffered solutions, water, and emulsions; compatible with stabilizers and preservatives to optimize stability and shelf life.
· In vitro and in vivo versatility: Suitable for both research and clinical applications, from preclinical studies to image‑guided procedures.
· Scalable coverage to match lesion size, shape, and treatment plan.
· Optional stabilizers and preservatives to maintain integrity
Who it’s for
· Interventional and surgical oncologists
· Radiologists and image‑guided therapy teams
· Biopharma and medtech developers advancing targeted, image‑visible therapeutics
Patent Family
Better Way to Biopsy - JHU Engineering Magazine
